Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections

PHASE3TerminatedINTERVENTIONAL

Enrollment

639

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Otitis Media

Interventions

DRUG

telithromycin (HMR3647)

Trial Locations (2)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi- Aventis Administrative Office, Paris